简介:
Overview
This paper describes methods for the generation, drug treatment, and analysis of patient-derived explants for assessing tumor drug responses in a live, patient-relevant, preclinical model system. The patient-derived explants provide immediate drug response data that can accurately predict patient outcomes.
Key Study Components
Area of Science
- Oncology
- Pharmacology
- Preclinical Models
Background
- Patient-derived explants (PDEs) are short-term models that mimic the tumor environment.
- PDEs allow for examination of drug responses in a 3D context.
- They can provide insights into drug metabolism and mechanisms of action.
- PDEs may help identify new pharmacodynamic biomarkers.
Purpose of Study
- To assess tumor drug responses using patient-derived explants.
- To develop a preclinical model that reflects patient outcomes.
- To explore the potential of PDEs in drug response prediction.
Methods Used
- Cleaning surgical equipment with 70% industrial methylated spirits.
- Preparing culture dishes with fresh medium on ice.
- Transferring specimens onto a dental wax surface.
- Slicing tissue into fragments of approximately two to three cubic millimeters.
Main Results
- PDEs provide immediate and relevant drug response data.
- They accurately predict patient outcomes based on drug responses.
- 3D context of PDEs mirrors the pathological features of tumors.
- Insights into drug mechanisms and potential biomarkers were identified.
Conclusions
- Patient-derived explants are a valuable tool for drug response assessment.
- They enhance the understanding of tumor biology and treatment efficacy.
- PDEs may facilitate the development of personalized medicine approaches.
What are patient-derived explants?
Patient-derived explants are tissue samples taken from patients that are used to study drug responses in a laboratory setting.
How do PDEs predict patient outcomes?
PDEs provide immediate drug response data that correlate with how patients are likely to respond to treatments.
What is the significance of using a 3D model?
A 3D model closely mimics the tumor environment, allowing for more accurate assessments of drug efficacy.
What methods are used to prepare PDEs?
Methods include cleaning surgical tools, preparing culture media, and slicing tissue samples into small fragments.
Can PDEs help identify new biomarkers?
Yes, PDEs have the potential to reveal new pharmacodynamic biomarkers related to drug responses.
What are the advantages of using PDEs over traditional models?
PDEs provide more relevant and immediate data that better reflect patient responses compared to traditional models.